Impedimed Limited
Impedimed Limited (IPD) is a medical technology company specializing in non-invasive bioimpedance spectroscopy for the assessment and management of lymphedema and other fluid-related conditions. The company operates primarily in the healthcare sector, focusing on improving patient outcomes through its innovative diagnostic and monitoring devices. Its core products include the SENSIMED and the SOZO systems, which are designed to provide clinicians with real-time data on fluid status in patients, particularly in oncology and chronic disease management.